RESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Clinical trials for RESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA trials appear
Sign up with your email to follow new studies for RESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on rare cancers before surgeons operate
Disease control OngoingThis study is testing whether giving immune-boosting drugs, with or without radiation, before surgery can help shrink tumors and improve outcomes for patients with two specific types of rare soft tissue cancers. The goal is to see if this pre-surgery treatment makes the cancer ea…
Matched conditions: RESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New Two-Pronged attack tested against rare cancers before surgery
Disease control OngoingThis early-stage study is testing the safety of combining two immunotherapy drugs, nivolumab and BO-112, given before surgery for patients with operable soft tissue sarcoma. The goal is to see if stimulating the immune system to attack the tumor before it is removed can improve o…
Matched conditions: RESECTABLE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC